作者
Jaromír Gumulec, M Masarik, S Krizkova, V Adam, J Hubalek, J Hrabeta, T Eckschlager, M Stiborova, René Kizek
发表日期
2011/11/1
来源
Current medicinal chemistry
卷号
18
期号
33
页码范围
5041-5051
出版商
Bentham Science Publishers
简介
Zinc(II) ions contribute to a number of biological processes e.g. DNA synthesis, gene expression, enzymatic catalysis, neurotransmission, and apoptosis. Zinc(II) dysregulation, deficiency and over-supply are connected with various diseases, particularly cancer. 98 % of human body zinc(II) is localized in the intracellular compartment, where zinc(II) is bound with low affinity to metallothionein (MT). Zinc transporters ZIP and ZnT maintain transmembrane transport from/to cells or organelles. Imbalance of their regulation is described in cancers, particularly prostate (down-regulated zinc transporters ZIP1, 2, 3 and ZnT-2) and breast, notably its high-risk variant (up-regulated ZIP6, 7, 10). As a result, intracellular and even blood plasma zinc(II) levels are altered. MT protects cells against oxidative stress, because it cooperates with reduced glutathione (GSH). Recent studies indicate elevated serum level of MT in a number of …
引用总数
2012201320142015201620172018201920202021202220232024137869114589683
学术搜索中的文章